SUMITOMO PHARMA CO LTD revenue for the last year amounted to 555.54 B JPY, the most of which — 510.72 B JPY — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 520.18 B JPY. The greatest contribution to the revenue figure was made by North America — last year it brought SUMITOMO PHARMA CO LTD 328.47 B JPY, and the year before that — 319.79 B JPY.